The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
companies founded by graduates and faculty in the last 10 years
countries
in Europe and #21 in the world for aerospace engineering
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Technion Professor Noam Adir’s creativity knows no bounds. He has invented spinach-powered electricity cells, as well as technology to harvest energy from photosynthetic bacteria found in ponds.
In this webinar, Prof. Adir talks about his equally exciting biomedical research, studying proteins that can serve as targets for novel drug development. He and his research team use X-ray crystallography to determine the 3D structure and function of biologically important molecules on the atomic level, a critical tool in finding new treatments. They have deposited nearly 50 structures in the Protein Data Bank, which archives the 3D structures of biological molecules found in all organisms from bacteria to humans.
Noam Adir holds the Bertha Hertz-Axel Chair in Chemistry in the Schulich Faculty of Chemistry at the Technion. His research focuses on the relationship between the 3D structure of proteins, such as enzymes, and their function.
Professor Alon Wolf joins to give an update about research and the campus-wide measures being taken both for students and professors in response to the COVID-19 pandemic. Prof. Wolf is Vice President for External Relations & Resource Development. A renowned researcher and entrepreneur, he has pioneered new frontiers in robotic technologies, and is the founder and director of the Biorobotics and Biomechanics Lab (BRML) in the Technion Faculty of Mechanical Engineering.
April 01, 2020
Learn about new antimicrobial drugs that are revolutionizing treatments and combating resistant infections effectively.
2 mins
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Videos / Faculty / Intelligent Drugs / Technion Institutional /
Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]
Can the future of nutrition be more personalized, even down to our biology? A new study from the Technion suggests it can. Researchers in the Faculty of Biotechnology and Food Engineering recently discovered that men and women digest milk and plant-based milk alternatives differently — a breakthrough that could have far-reaching implications for nutrition science, […]
This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.